These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10600691)

  • 1. Searching for drug targets in microbial genomes.
    Galperin MY; Koonin EV
    Curr Opin Biotechnol; 1999 Dec; 10(6):571-8. PubMed ID: 10600691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial targets and antibiotics: genome-based drug discovery.
    Gray CP; Keck W
    Cell Mol Life Sci; 1999 Nov; 56(9-10):779-87. PubMed ID: 11212338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of drug efflux pumps in bacterial multidrug resistance and virulence. Analysis to identify novel drug targets and counteract multidrug resistance and virulence].
    Nishino K
    Jpn J Antibiot; 2008 Apr; 61(2):105-13. PubMed ID: 18669419
    [No Abstract]   [Full Text] [Related]  

  • 4. Completely sequenced genomes of pathogenic bacteria: a review.
    Guzmán E; Romeu A; Garcia-Vallve S
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):88-98. PubMed ID: 18341921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Advances in the Identification and Characterization of Putative Drug and Vaccine Targets in the Bacterial Genomes.
    Shahbaaz M; Bisetty K; Ahmad F; Hassan MI
    Curr Top Med Chem; 2016; 16(9):1040-69. PubMed ID: 26303422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial genome sequencing and drug discovery.
    Allsop AE
    Curr Opin Biotechnol; 1998 Dec; 9(6):637-42. PubMed ID: 9889137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postgenomic analysis of bacterial pathogens repertoire reveals genome reduction rather than virulence factors.
    Merhej V; Georgiades K; Raoult D
    Brief Funct Genomics; 2013 Jul; 12(4):291-304. PubMed ID: 23814139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining bacterial genomes for antimicrobial targets.
    Loferer H
    Mol Med Today; 2000 Dec; 6(12):470-4. PubMed ID: 11099952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecology and Evolution of Chromosomal Gene Transfer between Environmental Microorganisms and Pathogens.
    Martínez JL
    Microbiol Spectr; 2018 Jan; 6(1):. PubMed ID: 29350130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial fitness and genome dynamics.
    Tønjum T; Seeberg E
    Trends Microbiol; 2001 Aug; 9(8):356-8. PubMed ID: 11519528
    [No Abstract]   [Full Text] [Related]  

  • 12. Crystallizing new approaches for antimicrobial drug discovery.
    Schmid MB
    Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we need new antibiotics? The search for new targets and new compounds.
    Spížek J; Novotná J; Rezanka T; Demain AL
    J Ind Microbiol Biotechnol; 2010 Dec; 37(12):1241-8. PubMed ID: 21086099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two-component signal transduction as attractive drug targets in pathogenic bacteria].
    Utsumi R; Igarashi M
    Yakugaku Zasshi; 2012; 132(1):51-8. PubMed ID: 22214580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repeats in bacterial genomes: evolutionary considerations].
    Smirnov GB
    Mol Gen Mikrobiol Virusol; 2010; (2):11-20. PubMed ID: 20545043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial agents in the future. The contribution of genomics to their design].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 1999; 44(12):5-14. PubMed ID: 10687027
    [No Abstract]   [Full Text] [Related]  

  • 17. Can virulence factors be viable antibacterial targets?
    Marra A
    Expert Rev Anti Infect Ther; 2004 Feb; 2(1):61-72. PubMed ID: 15482172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial virulence as a target for antimicrobial chemotherapy.
    Alksne LE; Projan SJ
    Curr Opin Biotechnol; 2000 Dec; 11(6):625-36. PubMed ID: 11102800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of genomics to bacterial pathogenesis.
    Field D; Hood D; Moxon R
    Curr Opin Genet Dev; 1999 Dec; 9(6):700-3. PubMed ID: 10607606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting conserved essential genes in bacteria: in silico identification of putative drug targets.
    Duffield M; Cooper I; McAlister E; Bayliss M; Ford D; Oyston P
    Mol Biosyst; 2010 Dec; 6(12):2482-9. PubMed ID: 20949199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.